Primary human immunodeficiency virus infection during pregnancy detected by repeat testing

Steven Nesheim, Denise J. Jamieson, Susan P. Danner, Robert Maupin, Mary Jo O'Sullivan, Mardge H. Cohen, Mayris P. Webber, Renata Dennis, Marc Bulterys

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: The purpose of this study was to describe characteristics of pregnant women with newly acquired human immunodeficiency virus (HIV) infection that was identified by repeat testing. Study Design: The Centers for Disease Control and Prevention-sponsored Mother-Infant Rapid Intervention at Delivery (MIRIAD) study, which was conducted in 6 US cities, encouraged repeat HIV testing during pregnancy to identify primary infections. Results: Fifty-four HIV-infected women were identified. Four primary HIV infections were recognized, with median estimated seroconversion at 22 weeks of gestation. All 4 women denied new sex partners, alcohol, and illegal drug use during pregnancy. Three of the 4 mother-infant pairs received antiretroviral medications. One infant was infected perinatally, with positive HIV DNA polymerase chain reaction at birth. Questionnaire data identified 2 additional women with HIV that was likely acquired during pregnancy (identified by rapid testing at labor and delivery), which suggests that 6 of 54 HIV-infected women (11%) in the MIRIAD study had primary infection during pregnancy. Conclusion: Repeat HIV testing in pregnancy can identify opportunities for antiretroviral prophylaxis and should be used in areas of high HIV prevalence.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume197
Issue number2
DOIs
StatePublished - Aug 2007

Fingerprint

Virus Diseases
HIV
Pregnancy
Mothers
DNA-Directed DNA Polymerase
Centers for Disease Control and Prevention (U.S.)
Infection
Pregnant Women
Alcohols
Parturition
Polymerase Chain Reaction

Keywords

  • HIV
  • perinatal
  • prevention
  • testing

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Nesheim, S., Jamieson, D. J., Danner, S. P., Maupin, R., O'Sullivan, M. J., Cohen, M. H., ... Bulterys, M. (2007). Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. American Journal of Obstetrics and Gynecology, 197(2). https://doi.org/10.1016/j.ajog.2007.03.030

Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. / Nesheim, Steven; Jamieson, Denise J.; Danner, Susan P.; Maupin, Robert; O'Sullivan, Mary Jo; Cohen, Mardge H.; Webber, Mayris P.; Dennis, Renata; Bulterys, Marc.

In: American Journal of Obstetrics and Gynecology, Vol. 197, No. 2, 08.2007.

Research output: Contribution to journalArticle

Nesheim, S, Jamieson, DJ, Danner, SP, Maupin, R, O'Sullivan, MJ, Cohen, MH, Webber, MP, Dennis, R & Bulterys, M 2007, 'Primary human immunodeficiency virus infection during pregnancy detected by repeat testing', American Journal of Obstetrics and Gynecology, vol. 197, no. 2. https://doi.org/10.1016/j.ajog.2007.03.030
Nesheim, Steven ; Jamieson, Denise J. ; Danner, Susan P. ; Maupin, Robert ; O'Sullivan, Mary Jo ; Cohen, Mardge H. ; Webber, Mayris P. ; Dennis, Renata ; Bulterys, Marc. / Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. In: American Journal of Obstetrics and Gynecology. 2007 ; Vol. 197, No. 2.
@article{b000f5274a4442ddb8af91778abf2f1d,
title = "Primary human immunodeficiency virus infection during pregnancy detected by repeat testing",
abstract = "Objective: The purpose of this study was to describe characteristics of pregnant women with newly acquired human immunodeficiency virus (HIV) infection that was identified by repeat testing. Study Design: The Centers for Disease Control and Prevention-sponsored Mother-Infant Rapid Intervention at Delivery (MIRIAD) study, which was conducted in 6 US cities, encouraged repeat HIV testing during pregnancy to identify primary infections. Results: Fifty-four HIV-infected women were identified. Four primary HIV infections were recognized, with median estimated seroconversion at 22 weeks of gestation. All 4 women denied new sex partners, alcohol, and illegal drug use during pregnancy. Three of the 4 mother-infant pairs received antiretroviral medications. One infant was infected perinatally, with positive HIV DNA polymerase chain reaction at birth. Questionnaire data identified 2 additional women with HIV that was likely acquired during pregnancy (identified by rapid testing at labor and delivery), which suggests that 6 of 54 HIV-infected women (11{\%}) in the MIRIAD study had primary infection during pregnancy. Conclusion: Repeat HIV testing in pregnancy can identify opportunities for antiretroviral prophylaxis and should be used in areas of high HIV prevalence.",
keywords = "HIV, perinatal, prevention, testing",
author = "Steven Nesheim and Jamieson, {Denise J.} and Danner, {Susan P.} and Robert Maupin and O'Sullivan, {Mary Jo} and Cohen, {Mardge H.} and Webber, {Mayris P.} and Renata Dennis and Marc Bulterys",
year = "2007",
month = "8",
doi = "10.1016/j.ajog.2007.03.030",
language = "English (US)",
volume = "197",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Primary human immunodeficiency virus infection during pregnancy detected by repeat testing

AU - Nesheim, Steven

AU - Jamieson, Denise J.

AU - Danner, Susan P.

AU - Maupin, Robert

AU - O'Sullivan, Mary Jo

AU - Cohen, Mardge H.

AU - Webber, Mayris P.

AU - Dennis, Renata

AU - Bulterys, Marc

PY - 2007/8

Y1 - 2007/8

N2 - Objective: The purpose of this study was to describe characteristics of pregnant women with newly acquired human immunodeficiency virus (HIV) infection that was identified by repeat testing. Study Design: The Centers for Disease Control and Prevention-sponsored Mother-Infant Rapid Intervention at Delivery (MIRIAD) study, which was conducted in 6 US cities, encouraged repeat HIV testing during pregnancy to identify primary infections. Results: Fifty-four HIV-infected women were identified. Four primary HIV infections were recognized, with median estimated seroconversion at 22 weeks of gestation. All 4 women denied new sex partners, alcohol, and illegal drug use during pregnancy. Three of the 4 mother-infant pairs received antiretroviral medications. One infant was infected perinatally, with positive HIV DNA polymerase chain reaction at birth. Questionnaire data identified 2 additional women with HIV that was likely acquired during pregnancy (identified by rapid testing at labor and delivery), which suggests that 6 of 54 HIV-infected women (11%) in the MIRIAD study had primary infection during pregnancy. Conclusion: Repeat HIV testing in pregnancy can identify opportunities for antiretroviral prophylaxis and should be used in areas of high HIV prevalence.

AB - Objective: The purpose of this study was to describe characteristics of pregnant women with newly acquired human immunodeficiency virus (HIV) infection that was identified by repeat testing. Study Design: The Centers for Disease Control and Prevention-sponsored Mother-Infant Rapid Intervention at Delivery (MIRIAD) study, which was conducted in 6 US cities, encouraged repeat HIV testing during pregnancy to identify primary infections. Results: Fifty-four HIV-infected women were identified. Four primary HIV infections were recognized, with median estimated seroconversion at 22 weeks of gestation. All 4 women denied new sex partners, alcohol, and illegal drug use during pregnancy. Three of the 4 mother-infant pairs received antiretroviral medications. One infant was infected perinatally, with positive HIV DNA polymerase chain reaction at birth. Questionnaire data identified 2 additional women with HIV that was likely acquired during pregnancy (identified by rapid testing at labor and delivery), which suggests that 6 of 54 HIV-infected women (11%) in the MIRIAD study had primary infection during pregnancy. Conclusion: Repeat HIV testing in pregnancy can identify opportunities for antiretroviral prophylaxis and should be used in areas of high HIV prevalence.

KW - HIV

KW - perinatal

KW - prevention

KW - testing

UR - http://www.scopus.com/inward/record.url?scp=34547696900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547696900&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2007.03.030

DO - 10.1016/j.ajog.2007.03.030

M3 - Article

VL - 197

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -